473 related articles for article (PubMed ID: 22998785)
41. Mother-to-child transmission of extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
Danino D; Melamed R; Sterer B; Porat N; Hazan G; Gushanski A; Shany E; Greenberg D; Borer A
J Hosp Infect; 2018 Sep; 100(1):40-46. PubMed ID: 29330015
[TBL] [Abstract][Full Text] [Related]
42. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France.
Rivard-Yazigi L; Zahar JR; Le Guillou S; Chalouhi C; Lecuyer H; Bureau C; Nassif X; Gendrel D; Abadie V
Am J Infect Control; 2013 Sep; 41(9):844-5. PubMed ID: 23465604
[TBL] [Abstract][Full Text] [Related]
43. Frequency of extended spectrum beta lactamase producing enterobacteriaceae among urinary pathogen isolates.
Afridi FI; Farooqi BJ; Hussain A
J Coll Physicians Surg Pak; 2011 Dec; 21(12):741-4. PubMed ID: 22166694
[TBL] [Abstract][Full Text] [Related]
44. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.
van den Bunt G; van Pelt W; Hidalgo L; Scharringa J; de Greeff SC; Schürch AC; Mughini-Gras L; Bonten MJM; Fluit AC
Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615600
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital.
Jolivet S; Vaillant L; Poncin T; Lolom I; Gaudonnet Y; Rondinaud E; Bendjelloul G; Lomont A; Lucet JC; Armand-Lefèvre L
Clin Microbiol Infect; 2018 Dec; 24(12):1311-1314. PubMed ID: 29549056
[TBL] [Abstract][Full Text] [Related]
46. Extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy companion animals living in nursing homes and in the community.
Gandolfi-Decristophoris P; Petrini O; Ruggeri-Bernardi N; Schelling E
Am J Infect Control; 2013 Sep; 41(9):831-5. PubMed ID: 23422230
[TBL] [Abstract][Full Text] [Related]
47. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
[TBL] [Abstract][Full Text] [Related]
48. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.
Girlich D; Bouihat N; Poirel L; Benouda A; Nordmann P
Clin Microbiol Infect; 2014 Apr; 20(4):350-4. PubMed ID: 23927757
[TBL] [Abstract][Full Text] [Related]
49. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage).
Mesa RJ; Blanc V; Blanch AR; Cortés P; González JJ; Lavilla S; Miró E; Muniesa M; Saco M; Tórtola MT; Mirelis B; Coll P; Llagostera M; Prats G; Navarro F
J Antimicrob Chemother; 2006 Jul; 58(1):211-5. PubMed ID: 16720567
[TBL] [Abstract][Full Text] [Related]
50. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
51. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge.
Zimmerman FS; Assous MV; Bdolah-Abram T; Lachish T; Yinnon AM; Wiener-Well Y
Am J Infect Control; 2013 Mar; 41(3):190-4. PubMed ID: 23449280
[TBL] [Abstract][Full Text] [Related]
52. Relating knowledge, attitude and practice of antibiotic use to extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage: results of a cross-sectional community survey.
Mo Y; Seah I; Lye PSP; Kee XLJ; Wong KYM; Ko KKK; Ong RT; Tambyah PA; Cook AR
BMJ Open; 2019 Mar; 9(3):e023859. PubMed ID: 30842108
[TBL] [Abstract][Full Text] [Related]
53. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G
Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641
[No Abstract] [Full Text] [Related]
54. Fecal carriage and intrafamilial spread of extended-spectrum β-lactamase-producing enterobacteriaceae following colonization at the neonatal ICU.
Strenger V; Feierl G; Resch B; Zarfel G; Grisold A; Masoud-Landgraf L; Dosch V; Riedl R; Zenz W; Müller W; Urlesberger B
Pediatr Crit Care Med; 2013 Feb; 14(2):157-63. PubMed ID: 23254982
[TBL] [Abstract][Full Text] [Related]
55. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae intestinal carriage among children aged under five in Lomé, Togo.
Nikiema Pessinaba C; Landoh DE; Dossim S; Bidjada B; Kere-Banla A; Tamekloe TA; Doumbia T; Douti K; Bakonde BV; Segbena AY
Med Mal Infect; 2018 Dec; 48(8):551-554. PubMed ID: 30190161
[No Abstract] [Full Text] [Related]
56. Multidrug-resistant ESBL-producing Enterobacteriaceae and associated risk factors in community infants in Lebanon.
Hijazi SM; Fawzi MA; Ali FM; Abd El Galil KH
J Infect Dev Ctries; 2016 Sep; 10(9):947-955. PubMed ID: 27694727
[TBL] [Abstract][Full Text] [Related]
57. Risk factors of fecal carriage with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients.
Ko YJ; Moon HW; Hur M; Yun YM
Am J Infect Control; 2013 Dec; 41(12):1241-3. PubMed ID: 23969111
[TBL] [Abstract][Full Text] [Related]
58. High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections.
Moremi N; Claus H; Rutta L; Frosch M; Vogel U; Mshana SE
J Hosp Infect; 2018 Sep; 100(1):47-53. PubMed ID: 29852267
[TBL] [Abstract][Full Text] [Related]
59. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.
Adler A; Baraniak A; Izdebski R; Fiett J; Salvia A; Samso JV; Lawrence C; Solomon J; Paul M; Lerman Y; Schwartzberg Y; Mordechai E; Rossini A; Fierro J; Lammens C; Malhotra-Kumar S; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M; Carmeli Y;
Clin Microbiol Infect; 2014 Aug; 20(8):O516-23. PubMed ID: 24450778
[TBL] [Abstract][Full Text] [Related]
60. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
